Lhasa Limited shared knowledge shared progress
Home > Library > Search the Library > Managing the risk of nitrosamine impurities
Publications
  • Highlighted Item:
  • Webinar:
  • Publisher:
    Pharmaceutical Technology
  • Publication Date:
    MAR 2021
  • Reference:
  • DOI:
  • PMID:
  • Publication Type:
    Other
  • Related Products:
  • Scientific Area:
  • Endpoint:
    • Carcinogenicity
    • Mutagenicity
  • Industry Type:
  • Related event:

Managing the risk of nitrosamine impurities

Bercu J; Curran T;

Scientists from IQ, in collaboration with Lhasa Limited and Leadscope Inc. (part of Instem), recruited a network with expertise in genetic toxicology, pathology, computational toxicology and risk assessment toxicology to better evaluate the safety aspects of NAs.

Visit site

Additional Documents

    Related Publications

    • Linked In
    • Twitter

    © 2021 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
    VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

    Apart from the free survey software, we also have access to QuestionPro's free survey templates . We've found many of them useful and powerful to collect insights from various stakeholders of our organization.